apomorphine has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giridharagopalan, S; Hamamoto, DT; Simone, DA | 1 |
| von Metzler, A | 1 |
2 other study(ies) available for apomorphine and EHS Tumor
| Article | Year |
|---|---|
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
Topics: Animals; Apomorphine; Benzoxazines; Cannabinoid Receptor Agonists; Catalepsy; Cyclohexanes; Cyclohexanols; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Morpholines; Naphthalenes; Phenols; Receptors, Cannabinoid; Sarcoma, Experimental | 2007 |
[Curative effects of diverse, centrally active drugs in rats poisoned with 3-methylcholanthrene (author's transl)].
Topics: Animals; Apomorphine; Brain; Electroencephalography; Ephedrine; Female; Injections, Subcutaneous; Male; Methylcholanthrene; Picrotoxin; Rats; Sarcoma, Experimental; Strychnine; Time Factors | 1975 |